Stratos Wealth Partners, Ltd. 10x Genomics, Inc. Transaction History
Stratos Wealth Partners, Ltd.
- $8.26 Billion
- Q4 2025
A detailed history of Stratos Wealth Partners, Ltd. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 14,052 shares of TXG stock, worth $223,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,052
Previous 13,102
7.25%
Holding current value
$223,286
Previous $153,000
45.75%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
355Shares Held
117MCall Options Held
266KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA13MShares$207 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$189 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$102 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.49MShares$87.3 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.44MShares$86.4 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.51B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...